infohep
  • Menu
  • Search
  • Home
  • News
  • About hepatitis
  • Services
  • Countries
  • About us
  • Twitter
  • Facebook
  • RSS
  • Home
  • About hepatitis
  • Factsheets

Factsheets

  • Hepatitis C treatment factsheet: Boceprevir (Victrelis)
  • Hepatitis C treatment factsheet: Daclatasvir (Daklinza)
  • Hepatitis C treatment factsheet: Harvoni (sofosbuvir + ledipasvir)
  • Hepatitis C treatment factsheet: Simeprevir (Olysio)
  • Hepatitis C treatment factsheet: Sofosbuvir (Sovaldi)
  • Hepatitis C treatment factsheet: Telaprevir (Incivo)
  • Hepatitis C treatment factsheet: Viekirax (paritaprevir/ombitasvir/ritonavir) and Exviera (dasabuvir)
  • Hepatitis C treatment factsheet: Zepatier (grazoprevir + elbasvir)
  • Hepatitis C treatment factsheet: Epclusa (sofosbuvir + velpatasvir)

  • Contact us
  • Terms and conditions
  • Accessibility
  • Privacy and cookies

Latest hepatitis news

Sign-up for our monthly email bulletin Follow us on Twitter Find us on Facebook

The information on this website is intended to support, rather than replace, consultation with a healthcare professional.

©NAM Publications 2017. All rights reserved. We are not responsible for the content of external websites.

We are grateful to Abbvie, Janssen, Merck and Gilead for funding infohep.org. Our funders have had no editorial control over the site’s content.

infohep

Latest treatment news and information for patient advocates and people working in hepatitis in Europe.

NAM working with the World Hepatitis Alliance and the European Liver Patients Association

www.infohep.org/page//about-us/Find-out-about-NAM/page/2626330//   www.worldhepatitisalliance.org   www.elpa-info.org